FLUORANTHENE METABOLISM - HUMAN AND RAT-LIVER MICROSOMES DISPLAY DIFFERENT STEREOSELECTIVE FORMATION OF THE TRANS-2,3-DIHYDRODIOL

被引:26
作者
DAY, BW
SAHALI, Y
HUTCHINS, DA
WILDSCHUTTE, M
PASTORELLI, R
NGUYEN, TT
NAYLOR, S
SKIPPER, PL
WISHNOK, JS
TANNENBAUM, SR
机构
[1] MIT,DEPT CHEM,DIV TOXICOL,ROOM 56309,CAMBRIDGE,MA 02139
[2] UNIV PITTSBURGH,DEPT ENVIRONM & OCCUPAT HLTH,PITTSBURGH,PA 15238
[3] UNIV PITTSBURGH,DEPT PHARMACEUT SCI,PITTSBURGH,PA 15238
关键词
D O I
10.1021/tx00030a008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The metabolism of the environmental carcinogen fluoroanthene by human liver microsomes was compared to that by liver microsomes from rats treated with Aroclor 1254. Although the human-derived system gave primarily one product, similar metabolites were noted from each system. Enantiomers of the major metabolic product, in both cases the trans-2,3-dihydrodiol, were separated by chiral stationary-phase chromatography. Absolute configurations were assigned by application of the benzoate exciton chirality rules to the CD spectra of the 4-(dimethylamino)benzoyl esters. Liver microsomes from Aroclor 1254-treated rats produced the RR enantiomer of the diol in 75-78% enantiomeric excess, while human liver microsomes produced this enantiomer in only 6-12% excess. The activities of these enantiomers were compared in Salmonella typhimurium strain TM677 mutagenicity assays employing the 9000g supernatant of Aroclor 1254-induced rat liver homogenates. Both the syn- and anti-2,3-dihydrodiol 1,10b-epoxides, which had only been inferred to be metabolites in previous studies, were isolated from the microsomal incubations by preparative reverse-phase HPLC. The evident exceptional aqueous stabilities of these diol epoxides were further examined by half-life determination experiments. Their tetrahydrotetrol hydrolysis products were also noted in the metabolite HPLC profiles. The structures of the tetrahydrotetrols were confirmed by total synthesis.
引用
收藏
页码:779 / 786
页数:8
相关论文
共 36 条
[21]   CHROMATOGRAPHIC AND CYTOGENETIC ANALYSIS OF INVIVO METABOLITES OF FLUORANTHENE [J].
POLCARO, C ;
NICOLETTI, I ;
OSSICINI, L ;
CAPONECCHI, G ;
COZZI, R ;
FIORE, M ;
PALITTI, F .
JOURNAL OF CHROMATOGRAPHY, 1988, 448 (01) :127-133
[22]   FLUORANTHENE - SYNTHESIS AND MUTAGENICITY OF 4 DIOL EPOXIDES [J].
RASTETTER, WH ;
NACHBAR, RB ;
RUSSORODRIGUEZ, S ;
WATTLEY, RV ;
THILLY, WG ;
ANDON, BM ;
JORGENSEN, WL ;
IBRAHIM, M .
JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (25) :4873-4878
[23]   SYNTHESIS OF THE ISOMERIC PHENOLS AND THE TRANS-2,3-DIHYDRODIOL OF FLUORANTHENE [J].
RICE, JE ;
LAVOIE, EJ ;
HOFFMANN, D .
JOURNAL OF ORGANIC CHEMISTRY, 1983, 48 (14) :2360-2363
[24]  
SHIMADA T, 1991, CANCER RES, V51, P5284
[25]   QUANTITATIVE FORWARD MUTATION ASSAY IN SALMONELLA-TYPHIMURIUM USING 8-AZAGUANINE RESISTANCE AS A GENETIC-MARKER [J].
SKOPEK, TR ;
LIBER, HL ;
KROLEWSKI, JJ ;
THILLY, WG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :410-414
[26]   HETEROGENEITY OF BIOTRANSFORMATION OF FLUORANTHENE IN PERIFUSED LIVER-CELLS [J].
STIER, A ;
SCHLENKER, A ;
SIDHU, J ;
KUHNLE, W ;
FINCH, SAE .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (01) :39-46
[27]   ABSOLUTE STEREOCHEMISTRY OF THE TRANS-DIHYDRODIOLS FORMED FROM BENZO[A]ANTHRACENE BY LIVER-MICROSOMES [J].
THAKKER, DR ;
LEVIN, W ;
YAGI, H ;
TURUJMAN, S ;
KAPADIA, D ;
CONNEY, AH ;
JERINA, DM .
CHEMICO-BIOLOGICAL INTERACTIONS, 1979, 27 (2-3) :145-161
[28]  
THAKKER DR, 1977, J BIOL CHEM, V252, P6328
[29]  
THILLY WG, 1980, CHEM MUTAGENS, V6, P331
[30]   SYNTHESES OF FLUORANTHENES .1. MICHAEL ADDITION OF FLUORENE AND OF METHYL FLUORENE-9-CARBOXYLATE TO CROTONONITRILE - SYNTHESES OF 2-METHYL-FLUORANTHENE AND OF 2-4-DIMETHYL-FLUORANTHENE [J].
TUCKER, SH .
JOURNAL OF THE CHEMICAL SOCIETY, 1949, (SEP) :2182-2186